Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05472519Completed
Open-label trial (2 arms), sponsored by Hospices Civils de Lyon. Primary endpoint: Percentage of circulating TFH lymphocyte subpopulation at Day 1. Started Oct 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05472519.